EKIMAS (ASNB) Stock Price, News & Analysis

Company Overview

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

Key Stats

• Today's Range: $3.75 to $3.75
• 50-Day Range: $3.50 to $5.00
• 52-Week Range: $0.55 to $1.75
• Volume: N/A
• Average Volume: 3,162 shs
• Market Capitalization: $21.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed this year?

EKIMAS's stock was trading at $9.00 at the beginning of the year. Since then, ASNB stock has decreased by 58.3% and is now trading at $3.75.
View the best growth stocks for 2025 here.

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) issued its earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.29 by $0.02.

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include Associated Banc (ASB), MediWound (MDWD), PermRock Royalty Trust (PRT), Meta Platforms (META), Adobe (ADBE), Actinium Pharmaceuticals (ATNM) and CytoDyn (CYDY).

Company Calendar

• Last Earnings: 10/16/2014
• Today: 6/20/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:ASNB
• Previous Symbol: AMEX:ASB
• CIK: 1011060
• Web: www.advbiomaterials.com
• Phone: (424) 256-8560
• Fax: 978-657-0074
• Employees: 11
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$290 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -7,902.31%
• Return on Assets: -5,274.01%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.12
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.03 per share
• Price / Book: 125.00

Miscellaneous

• Outstanding Shares: 5,799,000
• Free Float: 5,347,000
• Market Cap: $21.75 million
• Optionable: Not Optionable
• Beta: 0.37